VCYT

VERACYTE, INC.

Biotechnology · Biotechnology

$269.83 sample

+1.42 (+0.53%) 1D

Market cap

$1.61T

Price as of

2026-10-03

Latest filing

8-K · 2026-09-08

Alerts

8

Price$269.83 -0.84% 3M daily closessample

278.97264.96

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider sell: Chief Executive Officer
Sep 15INSInsider sell: 10% owner
Sep 08SECForm 144 filed
Sep 01INSInsider sell: Director
Aug 21INSInsider sell: EVP, Operations
Aug 18INSInsider buy: Chief Financial Officer
Aug 11SECDEF 14A filed
Aug 05INSInsider sell: General Counsel

Sign up to see the real VCYT record →

Company facts

SEC EDGAR registration

Name: VERACYTE, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -57sample, -100 to +100
Reporting currency: USD

Who is positioning in VCYT

sample

Insiders: 17 insider transactions over 90 days, net selling, $770.2M
Congress: 5 members traded over 90 days
Institutions · 13F: 26 funds hold $16.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$85.3B +17.9% y/y

Q4 2024Q3 2026

Inventory$48.3B +5.5% y/y

Q4 2024Q3 2026

Accounts receivable$37.7B +11.5% y/y

Q4 2024Q3 2026

Total debt$95.6B +6.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.27T +10.4% 3M
Sample peer B: $257.0B +15.0% 3M
Sample peer C: $953.9B +15.1% 3M
Sample peer D: $359.6B -8.5% 3M
Sample peer E: $642.4B +0.8% 3M